Dr. Medhat Faris - Medical Oncologist

Dr. Medhat Faris

Consultant Medical Oncologist
Languages Spoken: English & Arabic Types of Physician: Part Time
Book Now

Dr. Medhat Faris stands as a distinguished Consultant Oncologist, embodying a remarkable legacy of excellence in the dynamic realm of Medical Oncology. With an impressive trajectory that spans decades, his unwavering commitment to advancing the field is evident through his extensive experience and profound expertise. Earning his medical qualifications, an MBBCh, from the esteemed Faculty of Medicine at Assiut University, Egypt, in 1988, he embarked on a journey of relentless pursuit of knowledge and proficiency. This journey led him to attain an MSc in Clinical Oncology from Assiut University, Egypt, a significant achievement that solidified his foundation in the intricacies of cancer care and treatment strategies. His pursuit of excellence reached new heights as he completed his MD in Oncology from Assiut University, Egypt, in 1999. Further enriching his academic and practical prowess, he earned a prestigious Diploma in Medical Oncology and Radiation Therapy from The Royal College of Radiologists in London, UK, an accomplishment that not only expanded his horizons but also demonstrated his global engagement in advancing cancer care. Moreover, Dr. Medhat has been recognized and certified by the esteemed European Society for Medical Oncology (ESMO) in Geneva, Switzerland, an accolade that underlines his international recognition and contributions to the field.

Throughout his career, Dr. Medhat has etched a profound impact on the medical community through his contributions. A pinnacle of leadership, he assumed the role of Chairman of the Adult Medical Oncology Department, orchestrating a transformative era of progress. Under his visionary guidance, sub-specialization flourished, giving rise to dedicated clinics such as the breast clinic and colorectal clinic. He spearheaded the development of comprehensive cancer treatment guidelines, a testament to his dedication to standardizing and enhancing the quality of care. His dynamic engagement extended to the meticulous review and refinement of chemotherapy treatment protocols, attesting to his unrelenting pursuit of cutting-edge therapeutic advancements for the betterment of patients. He also championed audits and lean projects within his department, embodying a commitment to continuous improvement and streamlined processes.

Dr. Medhat has extensive clinical trial experience and has been involved in numerous international trials, contributing to the development of oncology treatment protocols and research. With extensive experience in treating various types of cancer, including breast cancer, lung cancer, and colorectal cancer, he offers personalized and evidence-based care to his patients. His commitment to continuous education and active participation in prestigious medical societies, such as The Royal College of Radiologists, The Royal College of Physicians, ESMO, ASCO, and the European Society of Breast Cancer Specialists, ensures that he stays updated with the latest advancements in Oncology.

Apart from his outstanding medical career, Dr. Medhat has also been recognized for his contributions to cancer research and the improvement of oncology services. He received awards from HH the Prince of Eastern Provence, KSA, for Cancer Research and Early Detection of Breast Cancer. He has authored numerous publications in reputable journals, and he has participated in various conferences and symposiums, both as a speaker and attendee. Beyond his professional endeavors, Dr. Medhat is actively involved in community activities and raising awareness about cancer. He has organized breast cancer awareness campaigns, lung cancer awareness programs, and educational initiatives for patients and their families. His dedication to cancer research, patient care, and community engagement has made him a respected and influential figure in the field of Oncology.


  • MBBCh, Assiut University, Assiut, Egypt
  • MSc Clinical Oncology, Assiut University, Assiut, Egypt
  • MD Oncology, Assiut University, Assiut, Egypt
  • Diploma in Medical Oncology and Radiation Therapy, The Royal College of Radiologists, London, UK


  • Consultant/Medical Advisor, Watson Health for Oncology, IBM Middle East, Dubai, UAE
  • Consultant Medical Oncologist, Zulekha Hospital, Dubai, UAE
  • Professor of Medical Oncology, South Egypt Cancer Institute, Assiut, Egypt
  • Chairman of Adult Medical Oncology Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia
  • Vice Dean for Graduate Studies and Researches, South Egypt Cancer Institute, Assiut, Egypt
  • Medical Director, Clinical Research & Medical Affairs, EMEA & Asia at Pharmaceutical Products Development (PPD), Cambridge, UK
  • Head of Medical Oncology and Senior Consultant, The Royal Hospital, Muscat, Sultanate of Oman
  • Medical Oncologist, Addenbrooke’s Hospital, Cambridge University, UK


  • The Royal College of Radiologists UK
  • The Royal College of Physicians UK
  • Certified member of the European Society of Medical Oncology (ESMO)
  • The American Society of Clinical Oncology (ASCO)
  • European Society of Breast Cancer Specialists
  • The Egyptian Cancer Society


Management and Treatment Plans For

  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Renal cell carcinoma
  • Ovarian cancer
  • Cervical cancer
  • Uterine cancer
  • Non Hodgkin’s Lymphoma
  • Hodgkin’s lymphoma
  • Prostate cancer
  • Testicular cancer
  • Bladder cancer
  • Renal cancer
  • Head and neck cancer
  • High-risk patients with breast cancer carrying BRCA1 and BRCA2 mutations